Comerica Bank’s RxSight RXST Stock Holding History

Comerica Bank’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$250	Sell	24 -238	-91%	-$2.39K	﹤0.01%	3667
2025 Q3	$2.35K	Buy	262 +36	+16%	+$316	﹤0.01%	3509
2025 Q2	$2.94K	Sell	226 -42	-16%	-$631	﹤0.01%	3450
2025 Q1	$6.76K	Sell	268 -457	-63%	-$13.6K	﹤0.01%	3267
2024 Q4	$24.9K	Buy	725 +191	+36%	+$8.61K	﹤0.01%	2973
2024 Q3	$26.4K	Hold	534	–	–	﹤0.01%	2963
2024 Q2	$32.1K	Sell	534 -1	-0.2%	-$57	﹤0.01%	2874
2024 Q1	$27.6K	Buy	535 +15	+3%	+$736	﹤0.01%	2943
2023 Q4	$21K	Buy	520 +152	+41%	+$4.46K	﹤0.01%	2957
2023 Q3	$10.3K	Buy	+368	New	+$11K	﹤0.01%	3200

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Comerica Bank's RXST Position: Q4 2025 in Review

Comerica Bank reduced its RxSight (RXST) stake by 91% in Q4 2025, selling an estimated $2.39K and leaving 24 shares worth $250. The position accounts for ﹤0.01% of the portfolio, ranked #3667.

Comerica Bank first reported a position in RXST in Q3 2023 and has held it in 10 quarters since. The position peaked at $32.1K in Q2 2024. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.

Comerica Bank held 24 shares of RxSight worth $250 as of Q4 2025.
Comerica Bank sold 238 RxSight shares in Q4 2025, an estimated $2.39K.
RxSight made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3667 holding.
Comerica Bank first reported a position in RxSight in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's RxSight position peaked at $32.1K in Q2 2024.
163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.